Free Trial

Baxter International (BAX) Competitors

Baxter International logo
$24.16 -0.53 (-2.13%)
Closing price 03:59 PM Eastern
Extended Trading
$24.20 +0.03 (+0.12%)
As of 07:04 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

BAX vs. AMN, DVA, EW, RMD, DXCM, STE, PODD, HOLX, GMED, and MASI

Should you be buying Baxter International stock or one of its competitors? The main competitors of Baxter International include AMN Healthcare Services (AMN), DaVita (DVA), Edwards Lifesciences (EW), ResMed (RMD), DexCom (DXCM), STERIS (STE), Insulet (PODD), Hologic (HOLX), Globus Medical (GMED), and Masimo (MASI). These companies are all part of the "medical" sector.

Baxter International vs. Its Competitors

Baxter International (NYSE:BAX) and AMN Healthcare Services (NYSE:AMN) are both medical companies, but which is the superior stock? We will contrast the two companies based on the strength of their valuation, media sentiment, analyst recommendations, risk, dividends, institutional ownership, earnings and profitability.

AMN Healthcare Services has lower revenue, but higher earnings than Baxter International. Baxter International is trading at a lower price-to-earnings ratio than AMN Healthcare Services, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Baxter International$10.89B1.14-$649M-$0.30-80.55
AMN Healthcare Services$2.77B0.28-$146.98M-$7.77-2.64

Baxter International pays an annual dividend of $0.68 per share and has a dividend yield of 2.8%. AMN Healthcare Services pays an annual dividend of $1.20 per share and has a dividend yield of 5.9%. Baxter International pays out -226.7% of its earnings in the form of a dividend. AMN Healthcare Services pays out -15.4% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years.

In the previous week, Baxter International had 2 more articles in the media than AMN Healthcare Services. MarketBeat recorded 8 mentions for Baxter International and 6 mentions for AMN Healthcare Services. AMN Healthcare Services' average media sentiment score of 1.50 beat Baxter International's score of 0.95 indicating that AMN Healthcare Services is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Baxter International
5 Very Positive mention(s)
2 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
AMN Healthcare Services
6 Very Positive mention(s)
0 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

Baxter International has a beta of 0.6, meaning that its stock price is 40% less volatile than the S&P 500. Comparatively, AMN Healthcare Services has a beta of 0.11, meaning that its stock price is 89% less volatile than the S&P 500.

Baxter International has a net margin of -1.42% compared to AMN Healthcare Services' net margin of -10.75%. Baxter International's return on equity of 16.96% beat AMN Healthcare Services' return on equity.

Company Net Margins Return on Equity Return on Assets
Baxter International-1.42% 16.96% 5.24%
AMN Healthcare Services -10.75%11.09%3.34%

90.2% of Baxter International shares are owned by institutional investors. Comparatively, 99.2% of AMN Healthcare Services shares are owned by institutional investors. 0.2% of Baxter International shares are owned by company insiders. Comparatively, 0.9% of AMN Healthcare Services shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term.

Baxter International currently has a consensus price target of $30.11, suggesting a potential upside of 24.61%. AMN Healthcare Services has a consensus price target of $28.25, suggesting a potential upside of 37.85%. Given AMN Healthcare Services' stronger consensus rating and higher possible upside, analysts plainly believe AMN Healthcare Services is more favorable than Baxter International.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Baxter International
1 Sell rating(s)
6 Hold rating(s)
3 Buy rating(s)
0 Strong Buy rating(s)
2.20
AMN Healthcare Services
1 Sell rating(s)
4 Hold rating(s)
3 Buy rating(s)
0 Strong Buy rating(s)
2.25

Summary

Baxter International beats AMN Healthcare Services on 9 of the 17 factors compared between the two stocks.

Get Baxter International News Delivered to You Automatically

Sign up to receive the latest news and ratings for BAX and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding BAX and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

BAX vs. The Competition

MetricBaxter InternationalMED PRODUCTS IndustryMedical SectorNYSE Exchange
Market Cap$12.68B$10.57B$5.69B$21.20B
Dividend Yield2.75%1.84%6.66%3.48%
P/E Ratio-80.5521.6182.6529.02
Price / Sales1.1430.86498.4450.28
Price / Cash5.1925.1325.7018.29
Price / Book1.763.5711.244.57
Net Income-$649M$212.34M$3.28B$999.06M
7 Day Performance-1.55%-1.16%0.15%-0.01%
1 Month Performance9.99%13.38%8.34%6.50%
1 Year Performance-36.31%-8.99%54.21%11.34%

Baxter International Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
BAX
Baxter International
4.658 of 5 stars
$24.17
-2.1%
$30.11
+24.6%
-34.9%$12.68B$10.89B-80.5538,000High Trading Volume
AMN
AMN Healthcare Services
4.506 of 5 stars
$20.69
-0.3%
$28.25
+36.5%
-60.8%$792.84M$2.98B-2.662,968Positive News
DVA
DaVita
4.3353 of 5 stars
$137.33
-2.2%
$164.00
+19.4%
-8.8%$9.82B$12.82B13.5076,000
EW
Edwards Lifesciences
4.3768 of 5 stars
$80.92
-1.1%
$85.90
+6.2%
+16.5%$47.51B$5.69B11.6415,800Positive News
Analyst Upgrade
RMD
ResMed
4.7587 of 5 stars
$285.76
-2.7%
$274.83
-3.8%
+12.1%$41.84B$5.15B30.0510,600Positive News
Analyst Upgrade
DXCM
DexCom
4.9786 of 5 stars
$75.96
-7.7%
$99.89
+31.5%
+8.7%$29.79B$4.03B52.7510,300Positive News
STE
STERIS
4.8813 of 5 stars
$248.56
-1.3%
$273.50
+10.0%
+1.7%$24.48B$5.46B38.0617,787Positive News
Analyst Revision
PODD
Insulet
4.2742 of 5 stars
$329.00
-0.5%
$332.71
+1.1%
+67.6%$23.16B$2.07B100.003,900Positive News
HOLX
Hologic
4.8941 of 5 stars
$67.13
-1.7%
$78.00
+16.2%
-17.4%$14.93B$4.04B27.857,063Positive News
Analyst Downgrade
GMED
Globus Medical
4.933 of 5 stars
$61.42
-1.8%
$87.64
+42.7%
-15.7%$8.30B$2.63B23.625,300Positive News
Analyst Revision
MASI
Masimo
4.4902 of 5 stars
$145.15
-2.3%
$193.60
+33.4%
+18.9%$7.89B$2.09B-17.045,600Positive News

Related Companies and Tools


This page (NYSE:BAX) was last updated on 9/2/2025 by MarketBeat.com Staff
From Our Partners